“TexRAD assists clinical decision-making by predicting the risk of disease and assessing the prognosis for cancer patients”– Professor Ken Miles,
Consultant Radiologist and TexRAD’s lead Clinical Director.
“The preliminary TexRAD results were impressive.– Dr Olga Strukowska,
I was able to identify an invasive breast cancer focus
within larger area of pre-operative, non-invasive disease”
Consultant Radiologist of the Western Sussex Hospitals Trust, Worthing
TexRAD is a software application that
analyses the textures in existing radiological scans to assist clinician in assessing
the prognosis of patients with cancer.
TexRAD is a novel sophisticated imaging risk stratification tool that analyses clinical diagnostic images. TexRAD is a software application that analyses textures (texture analysis), detecting and measuring ‘tumor complexity’ from these images, revealing more information from medical images than it is currently possible to see with the naked eye.
Currently, doctors rely on medical imaging (scans) to make decisions on patient care and treatment, but these are limited to what can be seen by the human eye. TexRAD takes these images, such as CT and MRI used to look for signs and symptoms of disease one step further.
Cancer treatments can be tailored to patient needs. It is hoped that TexRAD will potentially support early diagnosis in other diseases and long term conditions such as dementia and enable early intervention and reduce disease progression.